Name | Number of supported studies | Average coverage | |
---|---|---|---|
classical monocyte | 3 studies | 24% ± 3% |
Insufficient scRNA-seq data for expression of TFE3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 7485.28 | 1445 / 1445 | 100% | 58.72 | 183 / 183 |
thymus | 100% | 7208.62 | 653 / 653 | 100% | 87.07 | 605 / 605 |
uterus | 100% | 8168.79 | 170 / 170 | 100% | 56.40 | 459 / 459 |
lung | 100% | 8527.21 | 578 / 578 | 100% | 57.66 | 1153 / 1155 |
ovary | 100% | 7605.23 | 180 / 180 | 100% | 54.29 | 429 / 430 |
skin | 100% | 6109.22 | 1808 / 1809 | 100% | 56.23 | 471 / 472 |
stomach | 100% | 4636.34 | 358 / 359 | 100% | 46.68 | 286 / 286 |
brain | 100% | 5196.10 | 2634 / 2642 | 100% | 92.64 | 705 / 705 |
kidney | 100% | 5446.40 | 89 / 89 | 100% | 53.88 | 898 / 901 |
intestine | 100% | 6066.63 | 966 / 966 | 100% | 42.86 | 525 / 527 |
prostate | 100% | 6565.10 | 245 / 245 | 100% | 44.45 | 500 / 502 |
breast | 100% | 7607.20 | 459 / 459 | 99% | 56.34 | 1110 / 1118 |
bladder | 100% | 8021.38 | 21 / 21 | 99% | 49.05 | 500 / 504 |
adrenal gland | 100% | 9164.24 | 258 / 258 | 99% | 63.68 | 227 / 230 |
liver | 98% | 2665.94 | 222 / 226 | 99% | 33.06 | 400 / 406 |
pancreas | 91% | 1799.99 | 298 / 328 | 99% | 54.91 | 176 / 178 |
adipose | 100% | 8917.51 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 7561.70 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 44.36 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 48.12 | 29 / 29 |
peripheral blood | 100% | 9940.10 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 7131.49 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 51.63 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 18.96 | 1 / 1 |
heart | 98% | 3374.67 | 847 / 861 | 0% | 0 | 0 / 0 |
muscle | 98% | 2873.18 | 784 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007040 | Biological process | lysosome organization |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0045785 | Biological process | positive regulation of cell adhesion |
GO_0045670 | Biological process | regulation of osteoclast differentiation |
GO_0006959 | Biological process | humoral immune response |
GO_0002250 | Biological process | adaptive immune response |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0090336 | Biological process | positive regulation of brown fat cell differentiation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0120163 | Biological process | negative regulation of cold-induced thermogenesis |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0046983 | Molecular function | protein dimerization activity |
GO_0005515 | Molecular function | protein binding |
Gene name | TFE3 |
Protein name | Transcription factor E3 (Class E basic helix-loop-helix protein 33) (bHLHe33) |
Synonyms | BHLHE33 |
Description | FUNCTION: Transcription factor that acts as a master regulator of lysosomal biogenesis and immune response . Specifically recognizes and binds E-box sequences (5'-CANNTG-3'); efficient DNA-binding requires dimerization with itself or with another MiT/TFE family member such as TFEB or MITF . Involved in the cellular response to amino acid availability by acting downstream of MTOR: in the presence of nutrients, TFE3 phosphorylation by MTOR promotes its inactivation . Upon starvation or lysosomal stress, inhibition of MTOR induces TFE3 dephosphorylation, resulting in transcription factor activity . Specifically recognizes and binds the CLEAR-box sequence (5'-GTCACGTGAC-3') present in the regulatory region of many lysosomal genes, leading to activate their expression, thereby playing a central role in expression of lysosomal genes . Maintains the pluripotent state of embryonic stem cells by promoting the expression of genes such as ESRRB; mTOR-dependent TFE3 cytosolic retention and inactivation promotes exit from pluripotency (By similarity). Required to maintain the naive pluripotent state of hematopoietic stem cell; mTOR-dependent cytoplasmic retention of TFE3 promotes the exit of hematopoietic stem cell from pluripotency . TFE3 activity is also involved in the inhibition of neuronal progenitor differentiation (By similarity). Acts as a positive regulator of browning of adipose tissue by promoting expression of target genes; mTOR-dependent phosphorylation promotes cytoplasmic retention of TFE3 and inhibits browning of adipose tissue (By similarity). In association with TFEB, activates the expression of CD40L in T-cells, thereby playing a role in T-cell-dependent antibody responses in activated CD4(+) T-cells and thymus-dependent humoral immunity (By similarity). Specifically recognizes the MUE3 box, a subset of E-boxes, present in the immunoglobulin enhancer . It also binds very well to a USF/MLTF site . Promotes TGF-beta-induced transcription of COL1A2; via its interaction with TSC22D1 at E-boxes in the gene proximal promoter (By similarity). May regulate lysosomal positioning in response to nutrient deprivation by promoting the expression of PIP4P1 . . |
Accessions | ENST00000493583.5 [P19532-2] ENST00000315869.8 [P19532-1] P19532 ENST00000710095.1 [P19532-1] ENST00000710096.1 [P19532-2] |